Added to YB: 2026-08-13
Pitch date: 2026-08-11
TECN.SW [neutral]
Tecan Group AG
+0.94%
current return
Author Info
Lux Opes Research covers European companies. Lots of them. Sign up for the newsletter.
Company Info
Tecan Group AG provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally.
Market Cap
CHF 2.5B
Pitch Price
CHF 180.80
Price Target
N/A
Dividend
N/A
EV/EBITDA
28.53
P/E
-21.72
EV/Sales
2.78
Sector
Life Sciences Tools and Services
Category
turnaround
Tecan (TECN Switzerland): Growth returns as the Rewired program starts to deliver
TECN.SW (update): H1 sales CHF427.5m, -2.7% reported/+3.4% local ccy; adj EBITDA margin 15.1% (+180bp underlying, absorbing 120bp FX & 50bp tariffs). Both divisions back to growth, book-to-bill >1x, recurring 64.4% of Life Sciences. Rewired restructuring delivering. FY targets held: LSD growth, 15.5-16.5% margin. 2028 goal: CHF1bn rev, 20% margin.
Read full article (2 min)